Patent: 10,653,733
✉ Email this page to a colleague
Summary for Patent: 10,653,733
| Title: | Nutritional composition |
| Abstract: | The present invention provides nutritional compositions that are employed as oral supplementation to the human diet. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. The present invention is comprised of specific combinations of selected forms of unique sets of certain vitamins, minerals, protein, carbohydrates and phytochemicals. |
| Inventor(s): | Houn Simon Hsia |
| Assignee: | Individual |
| Application Number: | US16/156,990 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: |
More… ↓ |
Details for Patent 10,653,733
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Janssen Biotech, Inc. | SIMPONI ARIA | golimumab | Injection | 125433 | July 18, 2013 | ⤷ Start Trial | 2038-10-10 |
| Sanofi-aventis U.s. Llc | SOLIQUA 100/33 | insulin glargine and lixisenatide | Injection | 208673 | November 21, 2016 | ⤷ Start Trial | 2038-10-10 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,653,733
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| United States of America | 2024350569 | ⤷ Start Trial |
| United States of America | 2023113424 | ⤷ Start Trial |
| United States of America | 2022168369 | ⤷ Start Trial |
| United States of America | 2021283205 | ⤷ Start Trial |
| United States of America | 2020276254 | ⤷ Start Trial |
| United States of America | 2019038687 | ⤷ Start Trial |
| United States of America | 2016317593 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
